Allergy, Immunology, and ENT

Latest News

PDUFA date set for neffy 1 mg for children who weigh 33 lbs or more | Image Credit: © Postmodern Studio - © Postmodern Studio - stock.adobe.com.
PDUFA date set for neffy 1 mg for children who weigh 33 lbs or more

January 13th 2025

Neffy was first approved in September 2024 to treat type 1 allergic reactions in patients who weigh at least 66 lbs (33 kg).

New data: Viaskin Peanut patch improves treatment benefit through 36 months | Image Credit: © andersphoto - © andersphoto - stock.adobe.com.
New data: Viaskin Peanut patch improves treatment benefit through 36 months

January 9th 2025

2024’s critical needle-free approvals for pediatric anaphylaxis, influenza
2024’s critical needle-free approvals for pediatric anaphylaxis, influenza

December 26th 2024

Contemporary Pediatrics’ top 3 FDA approvals of 2024
Contemporary Pediatrics’ top 3 FDA approvals of 2024

December 18th 2024

Leniolisib: positive phase 3 data in children aged 4 to 11 years with APDS | Image Credit: © ธนากร บัวพรหม - © ธนากร บัวพรหม - stock.adobe.com.
Leniolisib: positive phase 3 data in children aged 4 to 11 years with APDS

December 11th 2024

More News

© 2025 MJH Life Sciences

All rights reserved.